. . . . . . . "[The anti-CCR7 mAb treatment (3 \uFFFD 200\uFFFD?g) was started on day 2 or 7 to target lymphoma cells in either a peri-implantation or a post-implantation stage, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:37+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .